Artificial Intelligence in Pulmonary Nodules
Sabbag’s contribution to the clinical validation of new technologies
Artificial Intelligence (AI) has emerged as a disruptive tool in radiological practice, particularly in the identification of malignant pulmonary nodules.
In the current clinical landscape, early detection is the key factor in improving the prognosis and survival rates of patients with suspected lung cancer.
Sabbag Radiólogos has led the implementation and evaluation of advanced AI solutions applied to chest Computed Tomography (CT) in the Colombian Caribbean.
Through a retrospective case series analysis, it has been documented how the integration of these tools optimizes diagnostic precision and clinical workflow.
Diagnostic support in pulmonary nodule detection
Detecting pulmonary nodules is a complex task due to overlapping anatomical structures and radiologist visual fatigue.
AI acts as a tireless 'second reader,' analyzing thousands of images to highlight findings that might otherwise go unnoticed.
In the study conducted at Sabbag, the AI algorithm was fundamental in flagging regions of interest in a series of 61 patients with suspected malignancy.
This technology does not replace the specialist; rather, it enhances their capability, allowing for more agile detection of diseases at early stages.
Local evidence demonstrates that AI support significantly improves diagnostic timeliness in real-world clinical conditions.
Clinical validation in real-world scenarios
The validation of tools such as Qure.ai in daily practice environments is crucial to ensuring safety and efficacy.
In the analyzed case series, 9.8% of the findings flagged by AI were pathologically confirmed as lung cancer following radiologist intervention and biopsies.
Significant differences were observed in AI utility based on patient profile, being most decisive in cases with subsequent radiological confirmation.
Sabbag radiologists integrate these results to differentiate benign from malignant nodules with greater confidence.
This process ensures the responsible use of technology, balancing algorithm sensitivity with the physician's clinical expertise.
Innovation focused on access and opportunity
Implementing AI at centers like Sabbag helps democratize access to high-precision diagnostics.
By optimizing workflows, the technology allows for the prioritization of critical cases for immediate specialist review.
This is especially valuable in contexts where care opportunity may be limited by a high demand for chest imaging.
The experience in Barranquilla provides solid evidence on how responsible innovation can close public health gaps.
The focus remains firmly on patient safety and the continuous improvement of data-driven medical decisions.
Artificial intelligence in radiology is a support tool that does not replace the professional's clinical judgment.
conclusion
Artificial Intelligence strengthens the diagnostic ecosystem by providing advanced detection tools.
Clinical validation at Sabbag confirms that AI, operating under medical supervision, reduces variability and improves precision.
These efforts directly contribute to optimizing response times and better therapeutic decision-making for the patient.